Rating History for Akari Therapeutics (AKTX) by Maxim Group

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/20/2026 Jason McCarthy Upgrade Buy
(Hold)
30.00
(N/A)
11.01
(10.37)
-5.81% Details